Rodríguez AAM, Abilio LCS, Cuellar PJC

Language: Spanish
References: 15
Page: 130-134
PDF size: 274.28 Kb.

ABSTRACT

Introduction: Nosocomial infections are common. Nosocomial pneumonia is the second most common among these infections and is the first in the Intensive Care Unit, where it reaches an incidence of 10-20%.
Objective: To determine the effect of progressive clinical assessment from 48-72 hours of initiation of antimicrobial therapy.
Method: A descriptive, prospective, cross-sectional research was performed in 57 patients (incidental sampling) diagnosed with painful ischemic heart disease who developed nosocomial pneumonia or bronchopneumonia and were admitted at the Cardiovascular Intensive Care Unit of Dr. Celestino Hernández Robau hospital, from January 3 to December 31, 2013.
Results: The initial clinical categorization favored the diagnosis of 50 early pneumonia and bronchopneumonia and 7 serious ones. Progressive assessment from 48-72 hours identified the unsatisfactory evolution in 6 (12%) of the early nosocomial pneumonia and in 4 (57.1%) of the serious ones.
Conclusions: The early progressive clinical assessment is useful for detecting response to antimicrobial treatment of nosocomial pneumonia and act accordingly.

REFERENCES

1. Cabrera Rayo A, Laguna Hernández G, Villagómez Ortiz AJ, Méndez Reyes R, Guzmán Gómez R. Neumonía adquirida en hospitales. Un problema co-mún que merece mayor atención. Med Int Mex. 2009;25:31-7.

2. Jordà Marcos R, Torres Martí A, Ariza Cardenal FJ, Álvarez Lerma F, Barcenilla Gaite F, Comisión de Expertos del Grupo de Trabajo de Enfermedades Infecciosas de la Sociedad Española de Medicina Intensiva, Crítica y Coronarias, et al. Recomenda-ciones para el tratamiento de la neumonía intra-hospitalaria grave. Enferm Infecc Microbiol Clin. 2004;22:471-85.

3. Mangino JE, Peyrani P, Ford KD, Kett DH, Zervos MJ, Welch VL, et al. Development and implementation of a performance improvement project in adult intensive care units: overview of the Improving Me-dicine Through Pathway Assessment of Critical Therapy in Hospital-Acquired Pneumonia (IMPACT-HAP) study. Crit Care [Internet]. 2011 [citado 26 Sep 2014];15:R38[10 p.]. Disponible en:http://www.ccforum.com/content/pdf/cc9988.pdf

4. García-San Miguel L, Cobo J, Martínez JA, Arnau JM, Murillas J, Peña C, et al. La «intervención del tercer día»: análisis de los factores asociados al segui-miento de recomendaciones sobre la prescripción de antibióticos. Enferm Infecc Microbiol Clin. 2014; 32:654-61.

5. Rhew DC, Tu GS, Ofman J, Henning JM, Richards MS, Weingarten SR. Early switch and early dis-charge strategies in patients with community-acquired pneumonia: a meta-analysis. Arch Intern Med. 2001;161:722-7.

6. Avdic E, Cushinotto LA, Hughes AH, Hansen AR, Efird LE, Bartlett JG, et al. Impact of an antimicro-bial stewardship intervention on shortening the duration of therapy for community-acquired pneu-monia. Clin Infect Dis. 2012;54:1581-7.

7. Kaki R, Elligsen M, Walker S, Simor A, Palmay L, Daneman N. Impact of antimicrobial stewardship in critical care: a systematic review. J Antimicrob Che-mother. 2011;66:1223-30.

8. Brar NK, Niederman MS. Management of commu-nity-acquired pneumonia: a review and update. Ther Adv Respir Dis. 2011;5:61-78.

9. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, et al. Guidelines for the management of adults with community-ac-quired pneumonia. Diagnosis, assessment of severi-ty, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001;163:1730-54.

10. 10.Johanson WG, Pierce AK, Sanford JP, Thomas GD. Nosocomial respiratory infections with Gram-neg-ative bacilli. The significance of colonization of the respiratory tract. Ann Intern Med. 1972;77:701-6.

11. 11.Álvarez Lerma F, Sánchez García M, Lorente L, Gor-do F, Añón JM, Álvarez J, et al. Paquete de medidas para la prevención de la neumonía asociada a la ventilación mecánica y su aplicación en las UVI españolas. El Proyecto «Neumonía Zero». Med In-tensiva. 2014;38:226-36.

12. 12.Apisarnthanarak A, Bhooanusas N, Yaprasert A, Mundy LM. Carbapenem de-escalation therapy in a resource-limited setting. Infect Control Hosp Epide-miol. 2013;34:1310-3.

13. 13.Dünser MW, Festic E, Dondorp A, Kissoon N, Gan-bat T, Kwizera A, et al. Recommendations for sepsis management in resource-limited settings. Intensive Care Med. 2012;38:557-74.

14. 14.Rojo Enríquez A. Rivera Benítez C. Neumonía aso-ciada a ventilación mecánica por Acinetobacter baumannii MDR en una unidad de terapia intensiva de tercer nivel. Acta Méd G Ang. 2014;12:57-64.

15. 15.Gupta D, Agarwal R, Aggarwal AN, Singh N, Mishra N, Khilnani GC, et al. Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommen-dations. Lung India. 2012;29:S27-62.